EI- Nile Co. for Pharmaceuticals and Chemical Industries (EGX:NIPH)
Egypt · Delayed Price · Currency is EGP 81.96
-0.94 (-1.13%)
At close: Oct 1, 2025
EGX:NIPH Income Statement
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 1,290 | 1,143 | 1,005 | 876.78 | 755.51 | Upgrade | |
Revenue Growth (YoY) | 12.86% | 13.66% | 14.65% | 16.05% | -7.02% | Upgrade |
Cost of Revenue | 881.75 | 890.14 | 733.17 | 654.21 | 554.43 | Upgrade |
Gross Profit | 407.83 | 252.44 | 272.05 | 222.57 | 201.08 | Upgrade |
Selling, General & Admin | 123.16 | 101.98 | 100.02 | 91.51 | 83.27 | Upgrade |
Other Operating Expenses | 5.34 | 6.94 | 9.27 | 5.63 | 22.21 | Upgrade |
Operating Expenses | 128.5 | 108.93 | 109.28 | 97.13 | 105.48 | Upgrade |
Operating Income | 279.33 | 143.52 | 162.76 | 125.44 | 95.6 | Upgrade |
Interest Expense | -70.21 | -25.32 | -13.72 | -3.18 | -3.67 | Upgrade |
Interest & Investment Income | 6.41 | 2.05 | 2.25 | 4.79 | 5.74 | Upgrade |
Currency Exchange Gain (Loss) | 4.72 | 9.76 | 7.88 | - | - | Upgrade |
Other Non Operating Income (Expenses) | -56.4 | -21.77 | -14.04 | -10.76 | -15.07 | Upgrade |
EBT Excluding Unusual Items | 163.86 | 108.24 | 145.13 | 116.3 | 82.6 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.31 | - | - | Upgrade |
Other Unusual Items | -0.62 | - | - | - | - | Upgrade |
Pretax Income | 163.23 | 108.24 | 145.44 | 116.3 | 82.6 | Upgrade |
Income Tax Expense | 37.5 | 18.01 | 26.22 | 26.63 | 18.18 | Upgrade |
Earnings From Continuing Operations | 125.73 | 90.23 | 119.21 | 89.67 | 64.42 | Upgrade |
Net Income | 125.73 | 90.23 | 119.21 | 89.67 | 64.42 | Upgrade |
Net Income to Common | 125.73 | 90.23 | 119.21 | 89.67 | 64.42 | Upgrade |
Net Income Growth | 39.35% | -24.32% | 32.94% | 39.20% | -31.01% | Upgrade |
Shares Outstanding (Basic) | 30 | 10 | 10 | 10 | 10 | Upgrade |
Shares Outstanding (Diluted) | 30 | 10 | 10 | 10 | 10 | Upgrade |
Shares Change (YoY) | 196.30% | - | - | - | - | Upgrade |
EPS (Basic) | 4.19 | 8.91 | 11.77 | 8.86 | 6.36 | Upgrade |
EPS (Diluted) | 4.19 | 8.91 | 11.77 | 8.86 | 6.36 | Upgrade |
EPS Growth | -52.97% | -24.32% | 32.94% | 39.20% | - | Upgrade |
Free Cash Flow | -472.96 | -155.57 | -284.07 | -43.83 | 75.09 | Upgrade |
Free Cash Flow Per Share | -15.77 | -15.37 | -28.06 | -4.33 | 7.42 | Upgrade |
Dividend Per Share | - | 3.710 | 5.000 | 2.970 | 2.000 | Upgrade |
Dividend Growth | - | -25.80% | 68.35% | 48.50% | - | Upgrade |
Gross Margin | 31.62% | 22.09% | 27.06% | 25.39% | 26.62% | Upgrade |
Operating Margin | 21.66% | 12.56% | 16.19% | 14.31% | 12.65% | Upgrade |
Profit Margin | 9.75% | 7.90% | 11.86% | 10.23% | 8.53% | Upgrade |
Free Cash Flow Margin | -36.68% | -13.62% | -28.26% | -5.00% | 9.94% | Upgrade |
EBITDA | 307.9 | 155.52 | 492.94 | 139.36 | 107.68 | Upgrade |
EBITDA Margin | 23.88% | 13.61% | 49.04% | 15.89% | 14.25% | Upgrade |
D&A For EBITDA | 28.57 | 12 | 330.18 | 13.91 | 12.08 | Upgrade |
EBIT | 279.33 | 143.52 | 162.76 | 125.44 | 95.6 | Upgrade |
EBIT Margin | 21.66% | 12.56% | 16.19% | 14.31% | 12.65% | Upgrade |
Effective Tax Rate | 22.98% | 16.64% | 18.03% | 22.89% | 22.01% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.